Regenerative medicine & medical device experts join cell therapy consulting firm
Bellingham, WA (Vocus) March 18, 2010 -- Cell Therapy Group is pleased to formally announce the addition of three new team members including Sarah A. Haecker, PhD as Director, Regenerative Medicine Business, Daniel A. Segal, as Director, Stem Cell & Medical Device Business, and John E. Hambor, PhD as Director, Stem Cell-based Drug Discovery.
“I am proud to be working with Sarah, Dan, and John as members of the Cell Therapy Group and am excited by the expertise this brings to the company and its clients,” says CTG Founder and Managing Director, Lee Buckler.
“Sarah’s breadth of expertise ranges from tissue engineering to stem cells and cell therapy”, continues Mr. Buckler. “She brings to our clients a focus on the essential elements of commercially viable product development and the corporate strategies required for their success. Sarah combines a solid technical background and understanding of the science of regenerative medicine with an outstanding and insightful business acumen and expertise honed over her executive career in the industry. She is the consummate business development professional who excels in putting parties together and driving deals to fruition.”
“Similarly,” says Buckler, “Dan Segal has a stellar track record of achieving top and bottom-line success for companies throughout the medical
Copyright©2010 Vocus, Inc.
All rights reserved